Prospective chart review observing depression and anxiety in cohort NTM patients at OHSU

Institution

PSU

Program/Major

Public Health

Degree

BS

Presentation Type

Presentation

Room Location

Smith Memorial Student Union, Room 294

Start Date

April 2019

End Date

April 2019

Rights

© Copyright the author(s)

IN COPYRIGHT:

http://rightsstatements.org/vocab/InC/1.0/

This Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s).

DISCLAIMER:

The purpose of this statement is to help the public understand how this Item may be used. When there is a (non-standard) License or contract that governs re-use of the associated Item, this statement only summarizes the effects of some of its terms. It is not a License, and should not be used to license your Work. To license your own Work, use a License offered at https://creativecommons.org/

Persistent Identifier

https://archives.pdx.edu/ds/psu/30980

Abstract

Background. Elderly adults, especially women, with chronic or infectious disease are at an especially high risk for mental health disorders such as depression and anxiety. Nontuberculous mycobacteria (NTM) cause chronic lung disease that is rare but increasingly common in Oregon, primarily affecting older adults. Little data is available on mental health in this population. The objective of the study is to build a rationale for anxiety and depression screening. Methods. The Patient Health Questionnaire (PHQ-8) and/or Generalized Anxiety Disorder (GAD-7) have been collected on a group of xxx patients enrolling in the Northwest NTM Biobank study by OHSU’s Center for Infectious Disease Studies team. Demographics and disease characteristics are collected as part of the Biobank. Additional data regarding the patient's anxiety/depression diagnosis history and psychotherapeutic medication prescription history will be collected for this sub-study through a chart review. Descriptive analysis will ascertain if the prevalence of patients who show depressive symptoms, anxiety, or both. Our analysis will determine the proportion of patients with NTM who lack history of mental health diagnosis or medication prescription, but screen positive using the Patient Health Questionnaire (PHQ-8) and/or Generalized Anxiety Disorder (GAD-7). Outcome. With these data I hope to provide a recommendation, once patients are found positive for NTM, if providers should screen for these two mental health diseases or not. I also hope to address the gap in research in this community, since there has been little published on the impact or prevalence on mental health illness in this population.

This document is currently not available here.

Share

COinS
 
Apr 3rd, 3:14 PM Apr 3rd, 3:27 PM

Prospective chart review observing depression and anxiety in cohort NTM patients at OHSU

Smith Memorial Student Union, Room 294

Background. Elderly adults, especially women, with chronic or infectious disease are at an especially high risk for mental health disorders such as depression and anxiety. Nontuberculous mycobacteria (NTM) cause chronic lung disease that is rare but increasingly common in Oregon, primarily affecting older adults. Little data is available on mental health in this population. The objective of the study is to build a rationale for anxiety and depression screening. Methods. The Patient Health Questionnaire (PHQ-8) and/or Generalized Anxiety Disorder (GAD-7) have been collected on a group of xxx patients enrolling in the Northwest NTM Biobank study by OHSU’s Center for Infectious Disease Studies team. Demographics and disease characteristics are collected as part of the Biobank. Additional data regarding the patient's anxiety/depression diagnosis history and psychotherapeutic medication prescription history will be collected for this sub-study through a chart review. Descriptive analysis will ascertain if the prevalence of patients who show depressive symptoms, anxiety, or both. Our analysis will determine the proportion of patients with NTM who lack history of mental health diagnosis or medication prescription, but screen positive using the Patient Health Questionnaire (PHQ-8) and/or Generalized Anxiety Disorder (GAD-7). Outcome. With these data I hope to provide a recommendation, once patients are found positive for NTM, if providers should screen for these two mental health diseases or not. I also hope to address the gap in research in this community, since there has been little published on the impact or prevalence on mental health illness in this population.